← Leaderboards
Robert E Gerszten
Beth Israel Deaconess Medical Center
$34,860,502
Attributed
$82,093,494
Total exposure
23
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $13.1M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$87,420,257 · 24
By mechanism
R01$44,057,524 · 11
U01$15,992,337 · 4
U24$15,979,691 · 1
U54$5,698,305 · 3
RF1$4,199,375 · 1
T32$675,145 · 1
Top collaborators
- Thomas J Wang26 shared
- Clary B Clish17 shared
- Steven A. Carr15 shared
- James Graham Wilson12 shared
- Christopher B Newgard11 shared
- Vasan S. Ramachandran11 shared
- Marc S Sabatine9 shared
- Xiao-Ou Shu6 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Jeremy Robbins$1,195,450
- Mark Andrew Sarzynski$4,936,886
- Ramesh K Ganju$10,257,043
- Martin R. Pollak$37,233,145
- Jon A Buras$408,200
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortPhenotypeMetabolomicsBaseRisk FactorsPathway InteractionsGeneticPlasmaSamplingProteinsInsightMetabolicProteomicsMetabolic DiseasesTechnologyBiological MarkersResponseBiologicalResearch PersonnelResourcesInstitutesFutureDiabetes MellitusFramingham Heart Study
Grant awards (107)
A biochemical roadmap of exercise signal$1,785,399
U24 · FY2025 · DK · contact PI
Metabolomic predictors of insulin resistance and diabetes$649,027
R01 · FY2025 · DK · contact PI
Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention$513,262
R01 · FY2025 · NR · contact PI
A biochemical roadmap of exercise signal$500,000
U24 · FY2025 · DK · contact PI
Proteomics of Cardiometabolic and Renal Traits in African Americans$494,567
R01 · FY2025 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$598,445
R01 · FY2024 · DK · contact PI
Proteomics of Cardiometabolic and Renal Traits in African Americans$569,531
R01 · FY2024 · HL · contact PI
Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention$512,548
R01 · FY2024 · NR · contact PI
A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events$439,554
R01 · FY2024 · HL
A biochemical roadmap of exercise signal$1
U24 · FY2024 · DK · contact PI
A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events$865,807
R01 · FY2023 · HL
Metabolomic predictors of insulin resistance and diabetes$621,278
R01 · FY2023 · DK · contact PI
Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention$514,929
R01 · FY2023 · NR · contact PI
Metabolic Phenotyping and Pharmocokinetics Core$388,093
U54 · FY2023 · NS · contact PI
A Biochemical Roadmap of Exercise Signaling$1,651,155
U24 · FY2022 · DK · contact PI
Plasma proteomics in CHS and population biology$1,073,392
R01 · FY2022 · HL
A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events$870,905
R01 · FY2022 · HL
Metabolomic predictors of insulin resistance and diabetes$621,842
R01 · FY2022 · DK · contact PI
Metabolic Phenotyping and Pharmocokinetics Core$580,506
U54 · FY2022 · NS · contact PI
Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention$574,424
R01 · FY2022 · NR · contact PI
A Biochemical Roadmap of Exercise Signaling$2,400,207
U24 · FY2021 · DK · contact PI
A Biochemical Roadmap of Exercise Signaling$1,291,879
U24 · FY2021 · DK · contact PI
Plasma proteomics in CHS and population biology$1,076,097
R01 · FY2021 · HL
A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events$873,210
R01 · FY2021 · HL
Metabolomic predictors of insulin resistance and diabetes$680,498
R01 · FY2021 · DK · contact PI
Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention$583,478
R01 · FY2021 · NR · contact PI
Metabolic Phenotyping and Pharmocokinetics Core$382,411
U54 · FY2021 · NS · contact PI
A Biochemical Roadmap of Exercise Signaling$2,777,531
U24 · FY2020 · DK · contact PI
Plasma proteomics in CHS and population biology$2,083,439
R01 · FY2020 · HL
Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans$721,062
R01 · FY2020 · HL · contact PI
Metabolic Phenotyping and Pharmocokinetics Core$384,749
U54 · FY2020 · NS · contact PI
Plasma Proteome and Risk of Alzheimer Dementia and Related Endophenotypes in the Framingham Study$2,730,110
RF1 · FY2019 · AG
A Biochemical Roadmap of Exercise Signaling$2,578,253
U24 · FY2019 · DK · contact PI
Plasma proteomics in CHS and population biology$1,799,932
R01 · FY2019 · HL
Plasma Proteome and Risk of Alzheimer Dementia and Related Endophenotypes in the Framingham Study$1,469,265
RF1 · FY2019 · AG
A Biochemical Roadmap of Exercise Signaling$1,430,327
U24 · FY2019 · DK · contact PI
Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans$1,032,458
R01 · FY2019 · HL · contact PI
Proteomic Pathway Discovery in Cardiovascular Disease$823,244
R01 · FY2019 · HL · contact PI
Metabolic Phenotyping and Pharmocokinetics Core$443,373
U54 · FY2019 · NS · contact PI
Metabolite profiles and the risk of diabetes in Asians$441,851
R01 · FY2019 · DK
Metabolite profiles and the risk of diabetes in Asians$191,052
R01 · FY2019 · DK
Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans$131,097
R01 · FY2019 · HL
Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans$1,442,862
R01 · FY2018 · HL
A Biochemical Roadmap of Exercise Signaling$1,335,796
U24 · FY2018 · DK · contact PI
Proteomic Pathway Discovery in Cardiovascular Disease$839,937
R01 · FY2018 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$666,859
R01 · FY2018 · DK · contact PI
Metabolite profiles and the risk of diabetes in Asians$605,033
R01 · FY2018 · DK
Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans$1,579,430
R01 · FY2017 · HL
Proteomic Pathway Discovery in Cardiovascular Disease$852,827
R01 · FY2017 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$666,859
R01 · FY2017 · DK · contact PI
Metabolite profiles and the risk of diabetes in Asians$655,327
R01 · FY2017 · DK
A Biochemical Roadmap of Exercise Signaling - Pilot Project for MoTrPAC Consortium$116,893
U24 · FY2017 · DK · contact PI
A Biochemical Roadmap of Exercise Signaling$112,250
U24 · FY2017 · DK · contact PI
Proteomic Pathway Discovery in Cardiovascular Disease$880,947
R01 · FY2016 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$675,687
R01 · FY2016 · DK · contact PI
Metabolite profiles and the risk of diabetes in Asians$669,827
R01 · FY2016 · DK
Metabolomic phenotyping ("Metabolomics")$645,687
U54 · FY2016 · NS · contact PI
Metabolite profiles and the risk of diabetes in Asians$1
R01 · FY2016 · DK
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes$2,033,252
U01 · FY2015 · HL
Metabolomic predictors of insulin resistance and diabetes$728,258
R01 · FY2015 · DK · contact PI
Metabolomic phenotyping ("Metabolomics")$641,596
U54 · FY2015 · NS · contact PI
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes$2,441,919
U01 · FY2014 · HL
Metabolomic Biomarkers of Early Myocardial Injury$734,748
R01 · FY2014 · HL · contact PI
Cell and Molecular Training for Cardiovascular Biology$675,145
T32 · FY2014 · HL · contact PI
Metabolomic phenotyping ("Metabolomics")$645,606
U54 · FY2014 · NS · contact PI
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes$2,334,891
U01 · FY2013 · HL
Metabolomic phenotyping ("Metabolomics")$766,445
U54 · FY2013 · NS · contact PI
Metabolomic Biomarkers of Early Myocardial Injury$649,776
R01 · FY2013 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$467,544
R01 · FY2013 · DK
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes$1,337,440
U01 · FY2012 · HL
Metabolomic phenotyping ("Metabolomics")$819,839
U54 · FY2012 · NS · contact PI
Metabolomic Biomarkers of Early Myocardial Injury$763,478
R01 · FY2012 · HL · contact PI
Discovery & Application of Proteomics-Based Biomarkers of Early Myocardial Injury$737,576
R01 · FY2012 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$481,852
R01 · FY2012 · DK
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes$853,124
U01 · FY2011 · HL
Metabolomic Biomarkers of Early Myocardial Injury$758,842
R01 · FY2011 · HL · contact PI
Discovery & Application of Proteomics-Based Biomarkers of Early Myocardial Injury$750,332
R01 · FY2011 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$636,575
R01 · FY2011 · DK · contact PI
Clinical characterization of the APOL1-associated phenotype$492,908
R24 · FY2011 · DK
Metabolomic Biomarkers of Early Myocardial Injury$805,350
R01 · FY2010 · HL · contact PI
Discovery & Application of Proteomics-Based Biomarkers of Early Myocardial Injury$721,603
R01 · FY2010 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$608,636
R01 · FY2010 · DK · contact PI
Discovery & Application of Proteomics-Based Biomarkers of Early Myocardial Injury$738,755
R01 · FY2009 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$596,402
R01 · FY2009 · DK · contact PI
Role of ILK in Leukocyte Recruitment$343,128
R01 · FY2009 · HL · contact PI
Novel Markers: Pathways, Prognosis, & Pharmacoproteomics$822,825
U01 · FY2008 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$609,852
R01 · FY2008 · DK · contact PI
Role of ILK in Leukocyte Recruitment$343,128
R01 · FY2008 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$17,583
R01 · FY2008 · DK · contact PI
Novel Markers: Pathways, Prognosis, & Pharmacoproteomics$1,520,680
U01 · FY2007 · HL · contact PI
Role of ILK in Leukocyte Recruitment$343,128
R01 · FY2007 · HL · contact PI
Novel Markers: Pathways, Prognosis, & Pharmacoproteomics$1,318,309
U01 · FY2006 · HL · contact PI
Role of ILK in Leukocyte Recruitment$353,376
R01 · FY2006 · HL · contact PI
Novel Markers: Pathways, Prognosis, &Pharmacoproteomics$1,664,949
U01 · FY2005 · HL
Biomarkers in "normal" myocardial ischemia and infarction$832,474
U01 · FY2005 · HL
Patients undergoing alcohol septal ablation for hypertrophic cardiomyopathy$832,474
U01 · FY2005 · HL
Role of ILK in Leukocyte Recruitment$405,627
R01 · FY2005 · HL
Clinical Evaluation of Novel Markers of MI$389,250
R01 · FY2005 · HL
Clinical Evaluation of Novel Markers of MI$389,250
R01 · FY2004 · HL
Clinical Evaluation of Novel Markers of MI$389,250
R01 · FY2003 · HL
CHEMOKINE SIGNAL IN MONOCYTE RECRUITMENT$346,000
R01 · FY2003 · HL
Clinical Evaluation of Novel Markers of MI$346,000
R01 · FY2002 · HL
CHEMOKINE SIGNAL IN MONOCYTE RECRUITMENT$346,000
R01 · FY2002 · HL
Chemokine Signaling in Monocyte Recruitment In Vivo$102,951
K02 · FY2002 · HL
CHEMOKINE SIGNAL IN MONOCYTE RECRUITMENT$363,700
R01 · FY2001 · HL
Chemokine Signaling in Monocyte Recruitment In Vivo$102,951
K02 · FY2001 · HL
MOLECULAR SIGNALS IN MONOCYTE RECRUITMENT$119,070
K08 · FY2000 · HL